Keyphrases
Gonadotropin-releasing Hormone
88%
Controlled Ovarian Stimulation
79%
Ovarian Stimulation
79%
In Vitro Fertilization
75%
IVF Outcome
59%
IVF Cycles
49%
Gonadotropins
48%
Multiple Dose
45%
Hormone Replacement Therapy
38%
Pregnancy Rate
35%
Polycystic Ovary Syndrome
32%
GnRH Antagonist Protocol
32%
High-quality Embryo
32%
Poor Responders
31%
Oocyte Yield
29%
Follicle
28%
Luteinizing Hormone
25%
GnRH Analogue
24%
Menopause
22%
Intracytoplasmic Sperm Injection
21%
Human Menopausal Gonadotropin
21%
Follicle-stimulating Hormone
21%
Letrozole
21%
Live Birth
21%
Mature Oocyte
19%
Ultrashort
18%
Improved Outcomes
18%
Israel
17%
Body Mass Index
16%
Future Fertility
16%
Oocyte number
16%
Ovarian Response
16%
Attitude towards Menopause
15%
Clinical Pregnancy Rate
15%
Estradiol
15%
Femarelle
14%
Elective Egg Freezing
14%
Methotrexate
14%
Unusual Presentation
14%
Amniotic Band Syndrome
14%
DT56a
14%
Ovulation Trigger
14%
Vaginal Progesterone
14%
Personal Care Products
14%
Phthalates
14%
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
14%
Suboptimal Responders
14%
Cycle Outcomes
14%
LH Level
13%
Pregnant Women
11%
Medicine and Dentistry
Oocyte
100%
Gonadotropin-Releasing Hormone
69%
Controlled Ovarian Hyperstimulation
67%
In Vitro Fertilisation
65%
Pregnancy Rate
42%
Embryo Quality
40%
Follitropin
39%
Hormone Substitution
38%
Follicle
30%
Gonadotropin
30%
Polycystic Ovary Syndrome
29%
Gonadorelin Agonist
29%
Progesterone
24%
Multiple Drug Dose
22%
Human Menopausal Gonadotropin
21%
Letrozole
21%
Intracytoplasmic Sperm Injection
21%
Embryo Transfer
20%
Diethylstilbestrol
17%
Luteinizing Hormone
16%
Chorionic Gonadotropin
15%
Amnion Band Syndrome
14%
Limb
14%
Genetic Screening
14%
Body Mass Index
13%
Health Care
13%
Retrospective Cohort Study
11%
Fertilization
11%
Ovulation
10%
Biopsy Technique
10%
Gonadorelin Antagonist
10%
Placenta
10%
Prevalence
9%
Pronucleus
9%
Messenger RNA
9%
Conception
9%
Diseases
9%
Population Research
9%
Zygote
9%
Health Behavior
9%
Blastocyst
9%
Pregnancy Complication
8%
Ovarian Reserve
8%
In Vitro
8%
Birth Rate
7%
Gonadorelin
7%
Abdominal Wall Defect
7%
Misoprostol
7%
Pregnancy Disorder
7%
Bone Density
7%